Expertise/Private
Equity
Private Equity
Expertise across the full lifecycle of private equity matters
The fast-changing nature of private equity transactions requires an agile full-service private equity practice. From fundraising and initial investments to exit transactions and closing down of the fund, and everything else that arises en route - our clients can count on strategic thinkers who offer creative solutions, and who understand their financial and commercial interests. This perspective, combined with our extensive experience, global presence and cross-practice approach with experts in all relevant areas, enables us to deliver appreciable added value for our clients.
We advise private equity funds, venture capital funds and other investment funds, limited partners, management teams and senior debt and mezzanine providers on their domestic and international transactions, and their legal and tax structuring.
We have in-depth knowledge in:
- private equity transactions ranging from private acquisitions to public-to-private transactions and from complex cross-border leveraged buy-outs to venture or growth capital investments, including advice on management participation schemes and on the tax and financing aspects of those transactions; and
- the formation and regulation of domestic and overseas private equity funds.
Contact
Lennard Keijzer
Partner
Arne Grimme
Partner
Related expertise
Mergers & AcquisitionsCapital MarketsFinancial Institutions & FintechRecent Matters
2 August 2024
G Square agrees on the sale of the Duomed Group to Palex Medical
De Brauw advised G Square on the contemplated sale of its portfolio company, the Duomed Group to Palex Medical through execution of a put option agreement. The Duomed Group is a dynamic organization with a well-established reputation and is active in consultancy, sales, integration, training and technical support of medical technology and devices for hospitals and medical practices. The Duomed Group is active in Denmark, Sweden, The Netherlands, Belgium, Luxembourg, France, Switzerland, the UK, Serbia and Slovenia. The envisaged transaction would form a truly pan-European platform, providing medical technology equipment and solutions across Northern, Western, and Southern Europe
31 July 2024De Brauw assists Aquiline on its sale of Quintes
De Brauw is advising Aquiline Capital Partners on the sale of its stake in Quintes, one of the largest independent insurance brokers in the Netherlands, together with the other shareholders being Gijsbert van de Nieuwegiessen (founder) and key management, to Brown & Brown, Inc.
18 July 2024De Brauw advises Astorg in connection with the EUR 1.4 billion continuation fund to support portfolio company Normec
De Brauw advises Astorg in connection with the announcement of the successful closing of the Normec Continuation Fund, capitalized by lead investors CVC Secondary Partners, Pantheon, Lexington Partners, and Eurazeo, alongside a diverse group of additional investors, including sovereign wealth funds, pension funds, asset managers, and family offices.
“The highly motivated team, with prominence in the private equity sphere, has made it a go-to firm for both domestic and international private equity clients.”
Insights
13 June 2024
De Brauw contributes Netherlands chapters to Private Equity: Lexology In-Depth and Lexology Panoramic
De Brauw's chapters in the 2024 edition of Lexology In-Depth: Private Equity provides a detailed overview of market developments and the regulatory regime for private equity transactions and fundraising in the Netherlands. The Investing chapter was written by Lennard Keijzer, Pete Lawley, Claudia van Rappard-Priem, Bas Boutellier and Bob de Waard. The Fundraising chapter was written by Mariska Enzerink and Abe Stegenga.
27 February 2024Dutch AG: dynamic incorporation clause passes to new owner after transfer of undertaking
In a case pending before the Dutch Supreme Court, Advocate General Hartlief has issued an important opinion on what happens to dynamic incorporation clauses in employment agreements in the case of a transfer of undertaking (TUPE). The European Court of Justice previously ruled that these clauses pass to the transferee, subject to certain strict conditions.
6 June 2023National security screening for investments – new Dutch regime up and running
Various geopolitical drivers have contributed to the proliferation of investment screening regimes that are based on national security concerns. Existing screening regimes have been expanded to include additional target activities. The EU has also been nudging member states to establish similar investment screening regimes or intensify the use of established ones. The vast majority of member states already have some form of foreign direct investment (FDI) control in place. The Netherlands, too, has adopted ministerial decrees necessary to implement its own investment screening system. This could affect the investment climate of the Netherlands, which has been historically known for its liberal disposition towards FDI. Investors contemplating acquisitions, or potential sellers, of designated vital providers or of companies active in sensitive technologies should anticipate uncertainty and a potential impact on transaction timelines due to an additional notification process.
